Invesco Ltd. raised its stake in Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 46.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 595,382 shares of the semiconductor company's stock after acquiring an additional 190,085 shares during the period. Invesco Ltd. owned approximately 1.83% of Silicon Laboratories worth $73,958,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Jones Financial Companies Lllp grew its holdings in shares of Silicon Laboratories by 44.5% in the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company's stock worth $28,000 after acquiring an additional 69 shares during the period. Headlands Technologies LLC bought a new position in Silicon Laboratories in the 4th quarter worth $70,000. Venturi Wealth Management LLC lifted its position in shares of Silicon Laboratories by 207.0% during the 4th quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company's stock valued at $98,000 after buying an additional 530 shares in the last quarter. Asset Management One Co. Ltd. purchased a new stake in shares of Silicon Laboratories in the fourth quarter worth $117,000. Finally, KBC Group NV raised its position in shares of Silicon Laboratories by 42.1% during the 4th quarter. KBC Group NV now owns 1,279 shares of the semiconductor company's stock valued at $159,000 after purchasing an additional 379 shares during the period.
Insider Activity at Silicon Laboratories
In related news, Director Navdeep S. Sooch sold 2,360 shares of the stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the completion of the transaction, the director now directly owns 400,567 shares of the company's stock, valued at $59,684,483. This trade represents a 0.59 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director William G. Bock sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $149.43, for a total transaction of $149,430.00. Following the sale, the director now directly owns 31,115 shares in the company, valued at approximately $4,649,514.45. This represents a 3.11 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,360 shares of company stock valued at $782,610 over the last 90 days. Insiders own 1.60% of the company's stock.
Silicon Laboratories Trading Up 0.6 %
Shares of SLAB traded up $0.50 during trading hours on Friday, reaching $90.50. 545,330 shares of the company traded hands, compared to its average volume of 332,119. The stock's fifty day moving average price is $121.99 and its 200 day moving average price is $121.56. The firm has a market cap of $2.94 billion, a price-to-earnings ratio of -15.24 and a beta of 1.33. Silicon Laboratories Inc. has a 12-month low of $82.82 and a 12-month high of $160.00.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last issued its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, hitting analysts' consensus estimates of ($0.11). The business had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The company's quarterly revenue was up 91.4% compared to the same quarter last year. During the same period last year, the company posted ($1.19) earnings per share. On average, research analysts forecast that Silicon Laboratories Inc. will post -0.97 earnings per share for the current year.
Analysts Set New Price Targets
Several analysts recently issued reports on the company. KeyCorp lifted their target price on Silicon Laboratories from $115.00 to $160.00 and gave the company an "overweight" rating in a research note on Wednesday, January 22nd. Needham & Company LLC restated a "buy" rating and issued a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Barclays lifted their price objective on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an "equal weight" rating in a research note on Friday, January 17th. StockNews.com cut shares of Silicon Laboratories from a "hold" rating to a "sell" rating in a research report on Thursday, March 27th. Finally, Stifel Nicolaus dropped their price target on Silicon Laboratories from $145.00 to $120.00 and set a "buy" rating for the company in a research report on Thursday. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, Silicon Laboratories presently has an average rating of "Hold" and an average target price of $133.70.
Read Our Latest Analysis on SLAB
Silicon Laboratories Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
See Also

Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report